Back
Pacific Biosciences of California Vs. NVIDIA Industry Stock Comparison
Sell
41
PACB
Pacific Biosciences of California
Last Price:
1.83
Seasonality Move:
-2.25%
Buy
59
NVDA
NVIDIA
Last Price:
887.72
Seasonality Move:
6.8%
Sell
41
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy, Sell or Hold?
- The current Pacific Biosciences of California [PACB] share price is $1.76. The Score for PACB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- PACB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
NVIDIA (NVDA)
is a Buy
Is NVIDIA a Buy, Sell or Hold?
- The current NVIDIA [NVDA] share price is $858.17. The Score for NVDA is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- NVDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PACB Stock Price Chart
What is Pacific Biosciences of California's stock price today?
-
The Pacific Biosciences of California share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing slight selling pressure.
PACB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 32.68 | Sell |
Chaikin Money Flow: | -2040628 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.46 - 3.36) | Sell |
Bollinger Bands (100): | (2.99 - 8.15) | Sell |
NVDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.14 | Sell |
Relative Strength Index (14 RSI): | 51.2 | Buy |
Chaikin Money Flow: | 25531041 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (822.35 - 893.37) | Buy |
Bollinger Bands (100): | (561.46 - 879.76) | Buy |
PACB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.55 | Buy |
20-day SMA: | 2.14 | Sell |
50-day SMA: | 3.4 | Sell |
200-day SMA: | 7.51 | Sell |
8-day EMA: | 1.67 | Buy |
20-day EMA: | 2.11 | Sell |
50-day EMA: | 3.34 | Sell |
200-day EMA: | 6.66 | Sell |
NVDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 844.29 | Buy |
20-day SMA: | 849.8 | Buy |
50-day SMA: | 863.01 | Sell |
200-day SMA: | 586.72 | Buy |
8-day EMA: | 847.71 | Buy |
20-day EMA: | 850.72 | Buy |
50-day EMA: | 825.76 | Buy |
200-day EMA: | 624.24 | Buy |
Pacific Biosciences of California Earnings Growth & PACB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.01 per share, an increase this year of $0.16 per share, and an increase next year of $0.19 per share.
NVIDIA Earnings Growth & NVDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.08 per share, an increase next quarter of $0.51 per share, an increase this year of $9.12 per share, and an increase next year of $12.68 per share.
Pacific Biosciences of California Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NVIDIA Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |